This study examained the effect of cognitive behavioral hypnotherapy on body dysmorphic disorder and depression and disabality of these patiants. This study utilized a single subject design wich include three baseline phase, treatment phase lasting fifteen session and follow up phase. The study society was the city of Sanandaj in spring 2015. Three patients with body dysmorphic disorder participated in this study by purposive available sampling. The Yale-Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder (BDD-YBOCS), Millon Clinical Multiaxial Inventory-III (MCMI-III) and clinical interview were used as diagnostic tools. The BDD-YBOCS, beck depression inventory (DBI-II) and Sheehan Disability Scale (SDS), were used every week in baseline phase and twice a week in treetment condition at beginning of each session.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2016050425838N2
Registration date:2016-09-04, 1395/06/14
Registration timing:retrospective
Last update:
Update count:0
Registration date
2016-09-04, 1395/06/14
Registrant information
Name
Morteza Abarin
Name of organization / entity
University of Kurdestan
Country
Iran (Islamic Republic of)
Phone
+98 17 3223 0046
Email address
m.abbarin@hum.uok.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research University of Kurdestan
Expected recruitment start date
2015-04-04, 1394/01/15
Expected recruitment end date
2015-06-05, 1394/03/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Efficacy of Cognitive Behavior Hypnotherapy for Body Dysmorphic Disorder
Public title
The Efficacy of Cognitive Behavior Hypnotherapy for Body Dysmorphic Disorder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: The age range between 18 and 48 years; BDD duration of at least 6 months; Read and write ability; Get score 21 or higher on BDD-YBOCS; Having a diagnosis of body dysmorphic disorder in the Diagnostic Interview
Exclusion criteria: Having serious thoughts about suicide based on scores of suicide item of Beck Depression Inventory ;Having simultaneous psychotherapy; Having simultaneous pharmacotherapy for psychological disorders; Having cosmetic surgery during treatment
Age
From 18 years old to 45 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
3
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
the study was single subject design
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of University of Kurdistan
Street address
Sanandaj, Pasdaran street
City
Sanandaj
Postal code
Approval date
2015-03-07, 1393/12/16
Ethics committee reference number
1179836
Health conditions studied
1
Description of health condition studied
boby dysmorphic disorder
ICD-10 code
F45.2
ICD-10 code description
The essential feature is a persistent preoccupation with the possibility of having one or more serious and progressive physical disorders. Patients manifest persistent somatic complaints or a persistent preoccupation with their physical appearance. Normal
Primary outcomes
1
Description
body dysmorphic disorder severity
Timepoint
three baseline spaced one week- every session during treatment- four month follow up
Method of measurement
Yale-Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder
Secondary outcomes
1
Description
depression severity
Timepoint
three baseline spaced one week- every session during treatment (twice a week)- four month follow up
Method of measurement
beck depression inventory (DBI-II)
2
Description
disability severity
Timepoint
three baseline spaced one week- every session during treatment (twice a week)- four month follow up